The COAST (Core Outcome set for Cranioplasty After Stroke or TBI) study established a standardized set of outcomes to be collected and reported after cranioplasty. This consensus-based COS is structured into four core domains:
To reduce heterogeneity in outcome reporting and improve comparability across clinical studies, registries, and clinical practice.
(†) Indicates outcome reached consensus in Delphi phase directly.
This COS defines “what to measure”, not “how to measure”. Further work is needed to select standard instruments for each outcome (e.g., mRS, EQ-5D, cognitive tests).
A standardized Core Outcome Set for cranioplasty after stroke or TBI was proposed by the COAST study (Mee et al., Brain & Spine, 2025), including:
Recommended timepoints: baseline, 3 months, 12 months.
| Domain | Assessment Tools / Indicators | Timepoints |
|---|---|---|
| Neurological recovery | GCS, NIHSS, cognitive testing | Pre-op, 3–12 months |
| Functional status | GOS, mRS, FIM | 3, 6, 12 months |
| Complications | Infection, bone resorption, seizures, hydrocephalus | Immediate–12 months |
| Cosmetic satisfaction | PROMs, interviews, satisfaction scales | 1, 3, 6 months |
| Quality of life | EQ-5D, SF-36, disease-specific PROMs | 3–12 months |
In a multi-phase consensus methodology including systematic review, qualitative study, two-round Delphi process, and final consensus meeting. Mee et al. from Cambridge, Oulu, Madrid, Ibadan, Bristol, Cali, Winnipeg, Perth, Modena, London, Lund, Worcester (MA), Adelaide, Milan, Norwich published in the Journal: *Brain & Spine* to develop an internationally agreed-upon core outcome set (COS) for cranioplasty following a decompressive craniectomy for stroke or traumatic brain injury. The COAST study successfully defined a 20-item core outcome set across four domains (life impact, pathophysiological manifestations, resource use/economic impact, mortality) based on structured consensus among a wide range of global stakeholders. This COS aims to enhance the consistency and comparability of future cranioplasty studies 1).
The COAST study represents an ambitious and commendable effort to bring standardization to an under-structured field—cranioplasty prognosis. By following the COMET methodology and involving a multidisciplinary and international panel, it enhances the legitimacy and breadth of the final COS.
Strengths: - Wide stakeholder inclusion ensures diverse perspectives (patients, surgeons, allied health professionals). - Rigid adherence to established consensus-building methodology. - The scale of participation (153 individuals across 16 countries) and structured Delphi rounds followed by a consensus meeting reflect robust procedural rigor. - A focused categorization of outcomes into clinically meaningful domains is pragmatic.
Weaknesses: - No formal validation of the selected outcomes in prospective cohorts—feasibility and sensitivity remain theoretical. - Regional representation appears skewed toward academic centers in high-income countries; the extent to which the COS reflects the realities of resource-limited settings is unclear. - The study refrains from discussing any potential conflicts between patient-centered outcomes and those favored by clinicians, nor does it address the weighting or prioritization of these 20 outcomes. - Lack of granularity in reporting stakeholder-specific scoring trends reduces interpretability of consensus dynamics.
Final Verdict: Solid methodology but lacks immediate translational validation. It is an important foundational step for future research standardization, though not yet a clinical tool. A validation phase in real-world clinical trials is critical.
Takeaway for Practicing Neurosurgeons: Begin familiarizing yourself with the COAST COS as a reporting standard, especially when engaging in clinical research on cranioplasty. It does not yet influence clinical decision-making directly.
Bottom Line: Methodologically sound initiative establishing a consensus-based framework for cranioplasty outcomes, but clinical adoption will hinge on future validation studies.
Rating: 7/10
Date of Publication: June 1, 2025